Document:

EX-10.4 - Retention Agreement, dated as of December 19, 2012

 Exhibit 10.4 
 RETENTION AGREEMENT 
 This RETENTION AGREEMENT (this “Agreement”)
is made and entered into as of the 19th day of December, 2012 (the “Effective Date”) by and between BioMimetic Therapeutics, Inc. (the “Company”) and Russ Pagano (the “Executive” and, with the
Company, the “Parties”). 
 WHEREAS, the Company has entered into a merger agreement dated November 19,
2012, by and among Wright Medical Group, Inc., a Delaware corporation (the “Parent”), Achilles Merger Subsidiary, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Parent, Achilles Acquisition Subsidiary, LLC,
a Delaware limited liability company and a direct wholly owned subsidiary of Parent, and the Company (as amended from time to time, the “Merger Agreement”); and 

WHEREAS, the Company desires to retain the Executive in the Executive’s current position and the Executive desires to remain so
employed from the Effective Date through and following the Closing (as such term is defined in the Merger Agreement); and 

WHEREAS, the Parties desire to set forth in this Agreement the terms and conditions under which the Executive will be eligible to receive
certain payments in connection with his continued employment with the Company through and following the Closing. 
 NOW,
THEREFORE, in consideration of the foregoing premises and the mutual promises, terms, provisions and conditions set forth in this Agreement, the Parties hereby agree as follows: 

1. Retention Payments. Executive will be entitled to receive certain retention payments in accordance with the following terms.

 (a) On the Closing Date (as such term is defined in the Merger Agreement), the Executive will be entitled to
receive an amount equal to $82,500 payable in a single lump sum within 10 business days following the Closing Date, subject to and conditioned upon the Executive remaining continuously employed by the Company from the date hereof through the Closing
Date. In the event that the Executive voluntarily resigns from his employment with the Company prior to the first anniversary of the Closing Date, the Executive must repay the Company an amount equal to $52,000 within 10 business days following such
resignation. 
 (b) On the one-year anniversary of the Closing Date, the Executive will be entitled to receive an
amount equal to $184,000 payable in a single lump sum within 10 business days following such one-year anniversary of the Closing Date, subject to and conditioned upon the Executive remaining continuously employed by the Company from the date hereof
through the one-year anniversary of the Closing Date. 
 2. Payment of 2012 Bonus. The Executive will be paid his bonus
for the 2012 fiscal year in the amount of $35,129 not later than December 31, 2012, subject to and conditioned upon the Executive remaining continuously employed by the Company from the date hereof through the date of payment. 

 3. Withholding. All payments made by the Company under this Agreement shall be
reduced by any tax or other amounts required to be withheld by the Company under applicable law. 
 4. Reduction in
Benefits. If at any time it is determined that payment of all amounts provided for under this Agreement (the “Retention Benefits”), together with any other payments and benefits payable to or for the benefit of the Executive in
connection with the transactions contemplated by the Merger Agreement (together with the Retention Benefits, the “Total Benefits”), would subject the Executive to an excise tax under Code Section 4999, and that a reduction in
the amount of the unpaid Retention Benefits would result in the amount of the Total Benefits, net of all federal, state and local income taxes on the Total Benefits (calculated at the highest applicable marginal rates) and any taxes on the Total
Benefits under Code Section 4999 (such amount, the “Net After-Tax Receipts”), being equal to or greater than the Net After-Tax Receipts that would result from payment of the unpaid Retention Benefits without reduction, then the
aggregate amount of any unpaid Retention Benefits shall be reduced to the smallest amount that results in the Net After-Tax Receipts being equal to or greater than the Net After-Tax Receipts that would result if the unpaid Retention Benefits were
reduced to any other amount. All determinations under this Section 4 shall be made by a qualified independent third party mutually acceptable to the Parties. 
 5. Assignment. Neither the Company nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent of the
other; provided, however, that the Company may assign its rights and obligations under this Agreement without the consent of the Executive in the event that the Company shall hereafter effect a reorganization, or consolidate with, or merge into, any
other Person (including pursuant to the Merger Agreement) or transfer all or substantially all of its properties, stock, or assets to any other Person. For purposes of this Section 5, the term “Person” means an individual, a
corporation, an association, a partnership, an estate, a trust and any other entity or organization and includes all persons and entities directly or indirectly controlling, controlled by or under common control with the Company, where control may
be by management authority, equity interest, contract, debt or other financing. This Agreement shall inure to the benefit of and be binding upon the Company and the Executive, their respective successors, executors, administrators, heirs and
permitted assigns. 
 6. Severability. If any portion or provision of this Agreement shall to any extent be declared
illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not
be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 
 7. Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving Party. The failure of either Party to require the performance of any term or
obligation of this Agreement, or the waiver by either Party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. 

  
 -2-

 8. Notices. Any and all notices, requests, demands and other communications provided
for by this Agreement shall be in writing and shall be effective when delivered in person, consigned to a reputable national courier service for next day or next business day delivery or deposited in the United States mail, postage prepaid,
registered or certified, and addressed to the Executive at his last known address on the books of the Company or, in the case of the Company, at its principal place of business, attention of the board of directors, or to such other address as either
Party may specify by notice to the other actually received. 
 9. Entire Agreement. This Agreement constitutes the entire
agreement between the Parties with respect to the subject matter herein and supersedes and terminates all prior communications, agreements and understandings, written or oral, including any employment agreement, with respect to any payments payable
pursuant to Section 1 and Section 2 of this Agreement. 
 10. No Contract of Employment. This
Agreement is not intended to and does not confer on the Executive or otherwise give rise to any right to continue in employment with the Company for any definite period of time or in any particular position. 

11. Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by an expressly
authorized representative of the Company’s board of directors. 
 12. Headings. The headings and captions in this
Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement. 

13. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be an original and all of which
together shall constitute one and the same instrument. 
 14. Governing Law. This contract shall be construed and
enforced under, and be governed in all respects by the laws of, the State of Delaware, without regard to the conflict of laws principles thereof. 
 [The remainder of this page has been left blank intentionally.] 

  
 -3-

 INTENDING TO BE LEGALLY BOUND, the Executive and the Company, by its duly authorized
representative, have executed this Agreement, as a sealed instrument as of the Effective Date. 
  

					
	THE EXECUTIVE	    	BIOMIMETIC THERAPEUTICS, INC.
		
	 /s/ Russ Pagano
	    	 /s/ Samuel E. Lynch

	Russ Pagano	    	By:	 	Samuel E. Lynch
		    	Title:	 	President and Chief Executive Officer

 [Retention Agreement Signature Page]Exhibit 10.24

 Exhibit 10.24 
 THE SECURITIES REPRESENTED BY THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN
ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR
AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS. 
 AUTOGENOMICS, INC. 
 Promissory Note 

 

			
	 No. 201301-001
	  	Vista, California
	 $ 2,400,000.00
	  	January 4, 2013

 FOR VALUE RECEIVED, AutoGenomics, Inc., a Delaware corporation (“Maker” or the
“Company”), hereby promises to pay to the order of A R Properties or registered assigns (“Holder”), the principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000.00), together with interest thereon
at the rate of eight and one half percent (8.5%) per annum (this “Note”), on or before March 31, 2013 (the “Maturity Date”), subject to the terms and conditions set forth hereinbelow. 

1. Subordination. 
 (a) Subordination to Senior Indebtedness. The indebtedness evidenced by this Note, and the payment of the principal hereof and interest hereon, is wholly subordinated, junior and subject in right
of payment, to the extent and in the manner hereinafter provided, to the prior payment of all Senior Indebtedness of the Company now outstanding or hereinafter incurred. “Senior Indebtedness” means the principal of, and premium, if
any, and interest on (i) all indebtedness of the Company for monies borrowed from banks, trust companies, insurance companies and other financial institutions, including commercial paper and accounts receivable sold or assigned by the Company
to such institutions, (ii) all indebtedness of the Company for monies borrowed by the Company from other persons or entities, (iii) obligations of the Company as lessee under leases of real or personal property, (iv) principal of, and
premium, if any, and interest on any indebtedness or obligations of others of the kinds described above assumed or guaranteed in any manner by the Company, (v) deferrals, renewals, extensions and refundings of any such indebtedness or
obligations described above, and (vi) any other indebtedness of the Company which the Company and the holders of more than 50% of the unpaid principal amount of the Company’s outstanding Subordinated Promissory Notes (the
“Subordinated Notes”) may hereafter from time to time expressly and specifically agree in writing shall constitute Senior Indebtedness. Notwithstanding the foregoing, “Senior Indebtedness” shall not include indebtedness of
the Company evidenced by the Subordinated Notes, which shall rank equally and ratably with this Note. 

  
 Page 1

 (b) Rights of Holders Unimpaired. The provisions of this Section 1 are, and are
intended solely, for the purposes of defining the relative rights of Holder and the holders of Senior Indebtedness and nothing in this Section 1 shall impair, as between the Company and Holder, the obligation of the Company, which is
unconditional and absolute, to pay to Holder the principal thereof, in accordance with the terms of this Note, nor shall anything herein prevent Holder from exercising all remedies otherwise permitted by applicable law or hereunder upon default,
subject to the rights set forth above of holders of Senior Indebtedness to receive cash, property or securities otherwise payable or deliverable to the holder of this Note. 
 2. Repayment. 
 (a) Repayment at the Maturity Date. The Company
shall repay all, but not less than all, of the outstanding principal amount of this Note, and all accrued and unpaid interest thereon, effective as of the Maturity Date by mailing a corporate check in such amount payable to Holder at Holder’s
address of record as contained herein or on file with the Company pursuant to notice given as provided herein, no later than ten (10) business days after the Maturity Date. 

(b) Prepayment Prior to the Maturity Date. The Company may prepay all or any portion of the outstanding principal amount of this
Note, together with all accrued and unpaid interest thereon, at any time or from time to time without premium or penalty. 
 (c)
Cancellation of Subordinated Note. Immediately upon repayment in full of this Note, this Note shall no longer be deemed to be outstanding and all rights with respect to this Note shall immediately cease and terminate as of the date of such
repayment. 
 3. Requirements for Transfer. This Note shall not be sold or transferred unless either (i) this Note
shall have been registered under the Securities Act of 1933, as amended (the “Act”), and all applicable state securities laws with respect thereto or (ii) the Company first shall have been furnished with an opinion of legal
counsel, reasonably satisfactory to the Company, to the effect that such sale or transfer is exempt from the registration requirements of the Act and all applicable state securities laws with respect thereto. 

4. Payment of Principal. All payments due and payable from Maker to Holder under this Note shall be made in lawful currency of the
United States of America. 
 5. Default. Upon the occurrence of an Event of Default (as defined below), the entire unpaid
portion of the principal amount of this Note, and all accrued and unpaid interest due Holder hereunder, shall automatically become due and payable. As used in this Note, “Event of Default” shall mean: (i) a receiver, trustee,
custodian or similar officer is appointed for Maker, or for any substantial part of its property and such appointment or proceedings remain unstayed or undismissed for a period of 90 days, (ii) any bankruptcy, insolvency, reorganization,
arrangement, readjustment of debt, dissolution, liquidation or similar proceedings under the laws of any jurisdiction is instituted (by petition, application or otherwise) against Maker and such appointment or proceedings remain unstayed or
undismissed for a period of 90 days, (iii) Maker admits in writing its inability to pay its debts when due, (iv) Maker makes an assignment for the benefit of creditors, (v) Maker applies for or consents to the appointment of any
receiver, trustee, custodian or similar officer for Maker or for any substantial part of its property, or (vi) Maker 

  
 Page 2

 
institutes (by petition, application or otherwise) or consents to any bankruptcy, insolvency, reorganization, arrangement, readjustment of debt, dissolution, liquidation or similar proceedings
under the laws of any jurisdiction against Maker. 
 6. Replacement. Whenever this Note shall be surrendered at the
principal executive office of the Company for transfer or exchange, accompanied by a written instrument of transfer in form reasonably satisfactory to the Company duly executed by Holder hereof or his, her or its attorney duly authorized in writing,
the Company shall execute and deliver in exchange therefor a new Note or Notes, as may be requested by Holder, in the same aggregate unpaid principal amount and payable on the same date as the principal amount of the Note or Notes so surrendered;
each such new Note shall be in such principal amount and registered in such name or names as Holder may designate in writing. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this
Note and of indemnity reasonably satisfactory to it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of this Note (in case of mutilation) the Company will make and deliver in
lieu of this Note a new Note of like tenor and unpaid principal amount. 
 7. General. 

(a) Successors and Assigns. This Note, and the obligations and rights of the Company hereunder, shall be binding upon and inure to
the benefit of the Company, Holder, and their respective heirs, successors and assigns. 
 (b) Notices. All notices,
requests, consents and demands shall be made in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of
the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at 2980 Scott St, Vista, California, 92081, and to Holder at the applicable address on record with the Company or at such
other address as the Company or Holder may designate by ten (10) days advance written notice to the other parties hereto. 

(c) Governing Law. This Note shall be construed and enforced in accordance with, and the rights of the parties shall be governed
by, the laws of the State of Delaware, without regard to its principles of choice of law. 
 (d) No Waiver. No delay or
omission on the part of Holder in exercising any right under this Note shall operate as a waiver of such right or of any other right of Holder, nor shall any delay, omission or waiver on any one occasion be deemed a bar to or waiver of the same or
any other right on any future occasion. 
 (e) Costs of Collection. The Company agrees to pay on demand all costs of
collection, including reasonable attorney’s fees, incurred by Holder in enforcing the obligations of the Company under this Note. 

  
 Page 3

 (f) Confidentiality. By his, her or its acceptance hereof, Holder agrees that he,
she or it will keep confidential and will not disclose, divulge or use for any unauthorized purpose any confidential, proprietary or secret information which Holder may obtain from the Company (i) pursuant to financial statements, reports and
other materials submitted by the Company to Holder or (ii) pursuant to visitation or inspection rights granted to Holder, unless such information is known, or until such information becomes known, to the public. 

(g) Headings. The headings in this Note are for purposes of reference only and shall not limit or otherwise affect the meaning of
any provision of this Note. 

  
 Page 4

 IN WITNESS WHEREOF, this Note has been executed and delivered on the date first above
written by the undersigned authorized representative of the Company. 
  

			
	AUTOGENOMICS, INC.
	a Delaware corporation
		
	 By:  
	 	 /s/ Thomas V. Hennessey, Jr.
		 	 Thomas V. Hennessey, Jr.
		 	 Its CFO and COO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]